The Deal
Wednesday, November 25, 
12:14 pm

Wall Street's bad chemical reaction to Lyondell deal

  Share     E-Mail    Discussion    Print Story

lyondell.jpgThe largest bankruptcy filing of the year continues to batter Wall Street.

Goldman Sachs Group Inc. disclosed in a Wednesday regulatory filing that it wrote down an $850 million loss in December linked to financing it provided to bankrupt chemical giant Lyondell Chemical Co., bringing the total reported losses among the five banks that committed $20.5 billion in loans for Basell AF's 2007 acquisition of Lyondell to about $3.67 billion.

Continue reading below

Also on Dealscape

"The firm incurred a loss of approximately $850 million in December 2008 for marking the bridge and bank loan facilities held in LyondellBasell Finance Company to expected recovery levels," Goldman said in a Jan. 27 filing with the Securities and Exchange Commission.

Since Lyondell's U.S. units filed Chapter 11 protection on Jan. 6, Goldman, Citigroup Inc. ($1.4 billion) and Royal Bank of Scotland Group plc ($1.42 billion) have all marked down losses as a result of the bankruptcy filing. UBS and Merrill Lynch & Co., now part of Bank of America NA, also arranged the financing, but have not reported write-downs to date. - John Blakeley





Post a comment





The Deal Pipeline

Deal Video


Inside The Deal: Pro Football Hall of Famer Steve Young tells us why quarterbacks make good PE investors.


More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

REIT IPO deja vu

Real estate sponsors that might wish to undertake an IPO will need to consider a wide variety of issues and begin to take action long before the first filing with the SEC.


Industry Insight

Loan-to-buy

Paulson's proposal to purchase an equity stake in Yellow Pages publisher Idearc is the second time in recent months an investor group has used its prepetition debt position to execute a bargain price 'exit LBO.'


Industry Insight

Managing your shareholder base

Growth companies and their PE sponsors should be wary of the pitfalls that arise when they layer on tiers of preferred stock.


footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.